A suitable carrier for camptothecin to act as therapy against the hepatitis C virus is presented. The carrier relies on a hybrid dendritic-linear-dendritic block copolymer chemical structure that consists of a pluronic core functionalized at both ends with bis-MPA dendrons. The amphiphilic pluronic core provides amphiphility and this allows the formation of micelles with a hydrophobic core and a hydrophilic shell. The dendrons admit the incorporation of multiple photoreactive groups that allow the covalent stabilization of the micelles by photocrosslinking. This process is clean and effective and affords crosslinked polymeric micelles (CLPM) susceptible of loading water soluble and non-water soluble molecules. Cell-uptake experiments using a newly designed fluorophore, derived from rhodamine B, demonstrate that the carrier favors the accumulation of its cargo within the cell. Furthermore, loaded with camptothecin, it 2 results efficient to fight against the hepatitis C virus while shows lower cytotoxicity than the free drug.
results efficient to fight against the hepatitis C virus while shows lower cytotoxicity than the free drug.
Introduction
Among the various nanocarriers described and assayed as for drug delivery systems, [1] cross-linked polymeric micelles (CLPM), formed by amphiphilic block-copolymers, have shown successful for biomedical applications. [2] First, they can fulfil those general requirements for drug delivery systems: water solubility, low toxicity, to increase the stability of the drug inside the living organisms, to facilitate cellular uptake compared to free drug and to produce its controlled release at a specific location. Second, the amphiphilic nature of the constituent polymer results in a hydrophobic core and a hydrophilic shell that allow encapsulation of both types of drug. Third, these nanoparticles offer further stability under high dilution conditions, below the critical micellar concentration, compared to other polymeric micelles. Indeed, cross-linking avoids its disintegration in the bloodstream and the release of the drug before reaching the target cell. Particularly, fixation of the micelle structure by light-induced covalent cross-linking, mostly employing acrylate reactive groups, [3] represents a clean and effective procedure to prepare stable polymer micelles that can hold either water-soluble and non-water soluble molecules and transport them through the bloodstream.
The features of nanocarriers, in general, and polymeric micelles, in particular, have been succesfully leveraged for anticancer therapies, [4] but are also attractive, and not extensively applied, for the development of systems to treat viral diseases. [5] In this respect, camptothecin (CPT), a poorly water soluble drug extracted in 1966 from the plant Camptotheca acuminate, which exhibits remarkable anticancer activity against different types of cancer, [6] has been recently described as a potent antiviral agent for Hepatitis C virus (HCV). [7] Indeed, a novel high throughput screening (HTS) strategy for identifying potential antivirals led to the identification of this new potential pharmacological use of CPT. [8] However, CPT has some drawbacks that limit its applications, i.e. negligible water solubility [9] and chemical instability due to hydrolysis of its lactone ring under physiological conditions. To overcome this issue, different strategies have been adopted by researchers and several carriers for CPT have been described. [10] Nevertheless, none of them have been explored as for their potential for antiviral therapies.
We herein present a new shell cross-linked polymeric micelle (CLPM) that shows high loading capacity for camptothecin while maintaining its antiviral activity and decreasing toxic effects. Based on our previous results about effective nanocarriers for antiviral drugs, [11] we have selected a hybrid dendritic-linear-dendritic block copolymer (HDLDBC) structure [12] for the design of a suitable amphiphilic macromer to form polymeric micelles with a hydrophobic core and a hydrophilic cross-linkable shell (Figure 1) . As for the lineal moiety, Pluronic F127 offers the ability to self-arrange in aqueous solutions forming micelles, which have proven to be excellent candidates for the physical encapsulation of hydrophobic drugs, [13] with enhanced drug transport across cellular barriers. [14] This lineal block-copolymer is functionalized at both ends with dendritic blocks. The characteristic multivalency of dendritic blocks affords the possibility of multifunctionalization with photoreactive groups in the periphery so that to permit micelle shell-photocrosslinking. Dendritic blocks are based on 2,2-bis(hydroxymethyl)propionic acid (bis-MPA) that provides a biocompatible and biodegradable scaffold. [15] In vitro cell-experiments have demonstrated that these nanoparticles permit the accumulation of their cargo within the cell using rhodamine B as a fluorescent probe. To further confirm cell internalization of the polymeric micelles, a new rhodamine B derivative with poor water solubility has been prepared to prevent fast release during the cell-internalization experiment. Finally, the potential of these nanoparticles as drug carriers for anti-HCV therapy has been studied with the poorly water-soluble drug CPT demonstrating that non-toxic CPT-loaded systems display similar anti-HCV-activity than free, and more toxic, CPT.
Results and discussion

Synthesis and characterization of the amphiphilic HDLDBC macromer
The macromer F127-Ac-8 was synthesized by divergent growing of 2 nd generation bis-MPA dendrons at both ends of commercial Pluronic F127 (Figure 2a) . The synthetic pathway consists of five steps that provide each intermediate with high yields after easy purification processes when needed, i.e. F127-Bn-2, F127-Bn-4 and F127-Ac-8 were precipitated with cold ethyl ether from the reaction mixture and F127-OH-4 and F127-OH-8 were used as-obtained without further purification.
The terminal hydroxyl groups of Pluronic were esterified using the benzylprotected anhydride derived from 2,2-bis(hydroxymethyl) propionic acid. This acylating agent was used in each step to grow the generation of the dendron following a debenzylation reaction to deprotect the terminal hydroxyl groups of the bis-MPA dendron, as described by Fréchet et al. [16] In the final stage, the terminal hydroxyl groups of both dendritic blocks were functionalized with acryloyl chloride in the presence of triethylamine. The final compound was fully characterized by Finally, the ability of the amphiphilic macromer F127-Ac-8 to self-aggregate in water so as to form micelles was determined by the pyrene method. This method is based on the displacement of the excitation maximum of pyrene from λ max =332 nm to λ max =335 nm when it is in a hydrophilic or a hydrophobic environment, respectively.
Once formed the aggregates, pyrene locates in the hydrophobic core of the micelles and hence the intensity of the excitation maximum at 335 nm (I 335 ) increases in detriment of the band at 332 nm (I 332 ). The representation of the I 335 /I 332 intensity ratio versus logarithm of the concentration of pyrene leads to a curve, where CMC is determined by calculating the intersection of the two straight lines.
In order to obtain the corresponding curve, F127-Ac-8 solutions were prepared at 0.001, 0.01, 0.1, 0.5, 1, 3, 5 and 10 mg/mL. Then, a similar amount of pyrene was added in each sample, with a final pyrene concentration of 6x10 
Preparation and morphological characterization of CLPMs
Upon formation of the micelles of F127-Ac-8, these could be stabilized by intramicellar photocrosslinking providing stable polymeric nanoparticles.
[3]
The photoinduced polymerization was carried out using 7.7 mg/mL aqueous solutions of the macromer containing 1 mg/mL of Irgacure 2959 as a biocompatible photoinitiator. The solution was irradiated with UV light, λ= 365 nm, at 25 ⁰C for 10 minutes. [3b,17] Subsequent dialysis at 4 ⁰C for 72 hours, and filtration through 0.2 µm cellulose acetate filters yielded a solution of nanoparticles at a final concentration of 1.9±0.1 mg/mL, which was used for further studies.
The so-prepared CLPMs were observed by TEM and SEM, and showed a spherical morphology (Figure 3) . The size of the photopolymerized particles was studied by DLS. A mean diameter of 127±9 nm (polydispersity: 0.56±0.07) was determined at 25 ºC, whereas a smaller mean diameter of 102±1 nm (polydispersity: 0.36±0.02) was determined at 37 ⁰C. The observed size variation with temperature confirmed that the nanoparticles display thermosensitive behavior, provided by Pluronic-F127. This temperature-dependent feature should also help to validate these CLPMs as suitable candidates for responsive drug carriers. [18] 2.3. Encapsulation of fluorescent probes and cell-uptake studies was calculated.
[2g]
Cell-uptake experiments were performed on HeLa cells. The cells were incubated with a solution of 0.6 mg/mL Rho-B loaded CLPMs for 4 h at 37 ºC. For the co-localization of Rho-B labeled CLPMs using confocal microscopy, staining of actin was performed with Alexa Fluor 488 Phalloidin. Confocal images (Figure 4b and 4c) suggest that F127-Ac-8 CLPMs allow the accumulation of Rho-B within the cell.
Nevertheless, since Rho-B is highly soluble in water, it is still possible that, in the high dilution conditions of culture media, Rho-B releases from the nanoparticles and enters into the cells by simple diffusion induced by a concentration gradient. 
Camptothecin encapsulation
In order to explore the possibility of these CLPMs to act as nanocarriers for anti HCV drugs, we undertook cytotoxicity and anti-HCV activity experiments based on encapsulated CPT.
Due to the insolubility of CPT in volatile water-soluble solvents, the evaporation method could not be employed for the encapsulation. contribution (-TΔS = -16.6 kcal/mol), with an unfavourable interaction enthalpy (ΔH = 6.8 kcal/mol), as expected for a predominantly hydrophobic interaction between the drug and the hydrophobic region of the CLPMs. Thus, the F127-Ac-8 CLPM-drug calorimetric titrations show that CPT interacts specifically with F127-Ac-8.
In-vitro anti-HCV studies
Once confirmed the cell internalization of the CLPMs to deliver a cargo and the possibility of loading CPT into these nanoparticles, the next step was to study the efficacy of the CPT-carrier system as for the inhibition of HCV replicon.
Nevertheless, prior to this study and in order to check the cytotoxicity of the system, we performed cell viability studies on HeLa cells for a range of concentrations of free CPT and F127-Ac-8/CPT CLPMs, close to those used in subsequent antiviral experiments. cell viability can be observed at 1 µM concentration, when the viral load has been nearly totally reduced. This would be specially interesting if CPT is intended as an antiviral agent, instead of an antitumor drug (its approved pharmaceutical application based on its high cytotoxicity in mammalian cells). [19] 
Conclusion
In conclusion, these results open new possibilities for the molecular design of crosslinked polymeric micelles for antiviral therapy applications. Particularly, the macromer F127-Ac-8, with a hybrid dendritic-lineal-dendritic block copolymer structure provides a molecular design that takes advantage of the amphiphilic nature of Pluronic and the multivalency provided by the dendritic blocks to achieve micelle stabilization by photocrosslinking and high loading capacity. The cytotoxicity of the drug is reduced when encapsulated, while the same efficacy of the free drug against the hepatitis-C virus is maintained. Interestingly, the multivalency of this dendritic block molecule can be exploited towards the multiconjugation of the polymeric micelles with active groups such as targeting moieties, offering future prospects for this sort of amphiphilic reactive compounds.
Experimental Section
Materials
Pluronic F127® (Average Mw= 12600), acryloyl chloride, 4-dimethyl-aminopyridine (DMAP), 2,2-bis(hydroxymethyl)propionic acid (bis-MPA), acryloyl chloride, triethylamine (TEA), 1,3-dicyclohexylcarbodiimide (DCC), benzaldehyde dimethyl acetal, p-toluensulfonic acid monohydrate, 2-hydroxy-1-(4-(hydroxyethoxy) phenyl)-2-methyl-1-propanone (Irgacure 2959, I2959), rhodamine B, CuSO 4 .5H 2 O, (L)-ascorbate and camptothecin were obtained from Sigma-Aldrich. Pluronic F127® was dried during 3 hours at 100 ⁰C under vacuum prior to use. All solvents were purchased from SigmaAldrich. 4-(dimethylamino) pyridinium 4-toluenesulfonate (DPTS), 6-azido-hexan-1-ol, 2-(but-3-ynoyl)-2-methylpropane-1,3-diyl distearate (HCC-2C 18 ) [11] and tris(benzyltriazolylmethyl)amine [20] (TBTA) were synthesized according to previous The product was isolated as a white powder after filtration. Yield: 95 %. 3, 17.4, 17.9, 42.4, 64.2, 68.5, 68.6, 69.1, 70.5, 72.9, 73.3, 75.1, 75.3, 75.5, 101.7, 126.2, 128.2, 128.9, 137.9, 173.9 F127-Bn-4. F127-OH-4 (4 g, 0.31 mmol) was dissolved in dry dichloromethane (15 mL). Benzylidene-2,2-bis(oxymethyl)propionic anhydride (2.13 g, 4.99 mmol) and DMAP (122 mg, 1 mmol) were added after dissolution. The reaction was stirred at room temperature for 72 hours. The excess of anhydride was quenched by adding methanol (6 mL). The mixture was stirred for 7 hours and the crude was precipitated in cold diethyl ether (1 L). The product was isolated after filtration as white solid. Yield: 95 %. 4, 17.6, 17.7, 42.5, 46.7, 64.1, 65.4, 68.5, 70.5, 72.9-73.3, 75.1-75.3-75.5, 101.6, 126.1, 128.0, 128.8, 137.7, 173 F127-OH-8. F127-Bn-4 (2.8 g, 0.21 mmol) was dissolved in ethyl acetate (100 mL).
Then Pd/C (10 % by weight) was added. After three vacuum-argon cycles, the reaction mixture was stirred at room temperature in hydrogen atmosphere overnight. The Pd/C was filtered off with Celite ® and the filtrate was evaporated to give the product as a white solid. Yield: Quant %. F127-Ac-8. F127-OH-8 (1.5 g, 0.11 mmol) was dissolved in of dry dichloromethane (20 mL). Then, triethylamine (0.55 ml, 3.98 mmol) and p-methoxyphenol (200 mg, polymerization inhibitor) were added. The reaction was cooled for 10 minutes in an ice bath and acryloyl chloride (0.29 ml, 3.61 mmol) was added dropwise under argon atmosphere. The mixture was stirred at room temperature for 14 hours in the dark. The solution was passed through a neutral alumina column and the filtrate was dried with Na 2 CO 3 during 2 hours. The product was purified by precipitation in cold diethyl ether (250 mL). The product was obtained after filtration as a white solid. Yield: 80 %. 3-17.4, 17.7, 45.8, 46.5, 64.9, 65.3-65.6, 68.5-68.7, 70.5, 72.9-73.3, 75.1-75.3-75.5, 127.7, 131.5, 165.4, 171.9-172.0 
Synthesis and characterization of Rho-B-2C 18
Rho-B-N 3 . Rhodamine B (1.00 g, 2.09 mmol) was dissolved in dry dichloromethane (70 mL). 6-azido-hexan-1-ol (602 mg, 4.18 mmol) and DPTS (492 mg, 1.67 mmol) were added after the dissolution. The reaction was stirred at 45 ºC under Argon atmosphere. DCC (861 mg, 4.18 mmol) was dissolved in dry dichloromethane (10 mL) and was added dropwise to the reaction mixture. It was stirred at 45ºC under Argon atmosphere overnight, protected from the light. A white precipitate appeared, which was filtered off. Dichloromethane (20 mL) were added to the filtrate. It was washed once with 100 mL of HCl 1.0 M and twice with 100 mL of brine. The organic phase was dried over anhydrous MgSO 4 and the solvent was evaporated under reduced pressure.
The crude product was purified on silica gel (DCM:MeOH = ramp from 10:0 to 9:1) to give a purple solid. Yield: 74 %. 25.4, 26.3, 28.2, 28.6, 46.2, 51.3, 65.5, 96.5, 113.6, 114.3, 126.3, 128.5, 130.0-130.3-130.4, 131.3, 133.1, 133.5, 155.5, 157.7, 165 7.07 (d, J = 8 Hz, 1.6H), 7.9 (d, J = 8 Hz, 1.6H) and 13 C NMR (21.3, 127.0, 129.7, 139.4, 158.9) . IR ( 17.8, 22.6-24.9, 25.2, 26.2, 28.1, 28.0, 29.0-29.2-29.3-29.4-29.6-30.0-31.9-34.0, 46.3, 50.7, 64.9, 65.5, 95.6, 113.6, 114.3, 119.1, 124.3, 126.3, 128.5, 130.0-130.3-130.4, 131.3, 133.0, 133.4, 155.5, 157.7, 165.1, 172.6, 173 
Chemical characterization techniques
The 1 H NMR and 13 C NMR spectra were recorded from their corresponding solutions in CDCl 3 , operating at 300/75 MHz (Bruker AMX300) or 400/100 MHz (Bruker AV-400).
IR spectra (Thermo Nicolet Avatar 360 FT-IR spectrometer) of F127-Bn-2, F127-OH-4, F127-Bn-4, F127-OH-8 and F127-Ac-8 were registered from molten polymer over a NaCl tablet whereas IR spectra (JACSO FT/IR-4100) of Rh-B-N3 and Rh-B-2C 18 were registered in ATR mode. Mass spectrometry was performed using a ESI Bruker Esquire 3000 plus spectrometer for Rh-B-N 3 and with a MALDI/TOF-MS Bruker Microflex system for the rest of the products. Elemental analysis was obtained in a microanalizer
Perkin Elmer CHN 2400. GPC was performed in a Waters 2695 apparatus equipped to a light scattering detector Waters 2424.
Preparation of CLPMs
A 10% (w/v) solution of F127-Ac-8 containing 0.1 % of photoinitiator I2959 was prepared in distilled water and kept overnight at 4ºC for complete dissolution of the polymer. The final solution was filtered through a 0.2 µm acetate cellulose filter to remove possible particles in suspension. By dilution with filtered distilled water containing 0.1 % of photoinitiator, 0.77% (w/v) solutions were prepared, which were used for photopolymerization. 0.77% precursor solutions were equilibrated for 1 hour at room temperature. 5 mL of 0.77% precursor solutions were light cured in a 6 cm diameter cylindrical glass container, using UV light (λ= 365 nm, 25 ºC, 10 minutes) with a distance of 8 cm between the lamp and the sample. The photopolymerized solution was dialyzed at 4 ºC for 72 hours, using a cellulose acetate membrane (Spectra / Por ® Biotech 300,000 MWCO (Spectrum)), with daily water changes. In order to remove larger aggregates, dialyzed samples were filtered with 0.2 µm cellulose acetate filters. To calculate the final concentration, known volumes of this dialyzed and filtered solution of CLPMs were dried by lyophilization in order to weigh the residue. A mean concentration of 1.9±0.1 mg/mL was determined from three freeze-drying experiments.
CLPM characterization
Dynamic light Scattering (DLS).
The size of the CLPMs was measured by DLS at two, 25 ºC and 37 ºC, using a Malvern Instrument Nano ZS that uses a He-Ne laser, 633 nm and a detection angle of 173 o .
Transmission Electronic Microscopy (TEM) and Scanning Electronic Microscopy (SEM).
The morphology of the CLMPs was observed by TEM (TECNAI G20, 200kV) and SEM (Inspect F50). TEM samples were prepared by adding a drop of CLMPs solution in a TEM grid (HOLLEY carbon film 300 mesh Cu, Agar, Scientific). Water from the sample was removed by capillarity with a filter paper. The sample was dried overnight in the darkness. SEM samples were prepared by adding a drop of CLMPs solution in a 12 mm glass coverslip. Sample was allowed to dry overnight in the darkness and gold sputtered before SEM observation.
Rho-B and Rho-B-2C 18 encapsulation and loading content determination
Rho-B or Rho-B-2C 18 
Isothermal titration calorimetry (ITC) assay
Binding of CPT to F127-Ac-8 polymer was determined with a high-sensitivity isothermal titration VP-ITC microcalorimeter (MicroCal, USA). Experiments were performed at 25°C in aqueous media with 3% of DMSO to increase solubility. 100 µM compound solution in the calorimetric cell was titrated with F127-Ac-8 polymer 30 µM solution. Control experiments were performed under the same experimental conditions.
The heat due to the binding reaction was obtained as the difference between the reaction heat and the corresponding heat of dilution, the latter estimated as a constant heat throughout the experiment, and included as an adjustable parameter in the analysis. Data were analyzed using software developed in our laboratory implemented in Origin 7
(OriginLab, USA).
Cells and replicon system
The highly permissive cell clone Huh 7-Lunet, as well as Huh 7 cells containing subgenomic hepatitis C virus (HCV) replicons I389luc-ubi-neo/NS3-3'/5.1 (Huh 5-2), I377NS3-3'/wt (Huh 9-13) or I389/hygro-ubi-NS3-3/5.1 (a kind gift from Dr. V.
Lohmann and Dr. R. Bartenschlager) have been described recently. [21] [22] [23] [24] Briefly, this system allowed the efficient propagation of genetically modified HCV RNAs (replicons) in a human hepatoma cell line (Huh). The amount of the RNA that has been transcribed and translated is determined through the quantification of a reporter contained in the replicon system (luciferase). The amount of luminescence detected (after adding the substrate specific for this enzyme) is proportional to the virus replication rate. [21] [22] [23] [24] Cells were grown in Dulbecco's modified Eagle's medium (DMEM; Gibco, Belgium) supplemented with 10% heat-inactivated fetal bovine serum (PAN-Biotech GmbH, Germany), 1X non-essential amino acids (Gibco), 100 IU/mL penicillin (Gibco), 100 µg/mL streptomycin (Gibco), and 250 µg/mL geneticin (G418; Gibco).
Antiviral assay with Huh 5-2 Cells
Antiviral assays for assessing the efficacy of the F127-Ac-8/CPT CLPMs system were performed as described in literature. [21] [22] [23] [24] [25] Briefly, Huh 5-2 cells were seeded at a density of 510 3 cells per well in a tissue culture-treated white 96-well view plate (Techno Plastic Products AG, Switzerland) in complete DMEM supplemented with 250 µg/mL G418. After incubation for 24 hours at 37°C medium was removed and 2-fold serial dilutions in complete DMEM (without G418) of the F127-Ac-8/CPT CLPMs were added in a total volume of 100 µL. After 3 days of incubation at 37°C cell culture medium was removed and luciferase activity was determined using the Bright-Glo TM Luciferase Assay System (Promega Corporation, The Netherlands). The luciferase signal was measured using a Synergy HT Multimode Reader (BioTek Instruments Inc, USA). The 50% effective concentration (EC50) was defined as the concentration of compound that reduced the luciferase signal by 50%.
Cytostatic assay
Cytostatic assays for assessing the cell viability of the F127-Ac-8/CPT CLPMs were performed as described in literature. [21] [22] [23] [24] Briefly, HeLa and Huh 5-2 cell lines were seeded at a density of 510 3 cells per well of a 96-well plate in complete DMEM (with the appropriate concentrations of G418, in case of Huh 5-2). Serial dilutions of the test compounds in complete DMEM (without G418) were added 24 hours after seeding.
Cells were allowed to proliferate for 3 days at 37°C, after which the cell number was determined by CellTiter 96 AQ ueous One Solution Cell Proliferation Assay (Promega Corporation). The 50% cytostatic concentration (CC50) was determined employing the dose-response equation (i.e., Hill equation). All the experiments with HeLa and Huh5-2 cells were carried out in triplicate and each experiment was repeated three different days.
Supporting Information
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Unspecific cytotoxicity of CLPMs
The cytotoxicity of CPLMs in HeLa cells was also checked at concentrations higher than those used for anti-HCV experiments.
HeLa cells (Homo sapiens cervix adenocarcinoma, Cancer Research UK, Cell Lines Services) were cultured in DMEM containing 4.5 g/L D-Glucose and 4 mM LGlutamine. Also, 10% heat-inactivated fetal bovine serum (FBS), 1%
penicillin/streptomycin and 1% amphotericin B were added to complement the media.
HeLa cells were maintained at 37⁰C in normoxic conditions (21% O 2 , 5% CO 2 ).
HeLa cells were seeded at a density of 5·10 3 cells per well in 96 well-plates. After 24 hours of incubation culture medium was removed and F127-Ac-8 CLPMs solutions
were added. CLPMs were diluted in complete medium /DEMEM) and tested at three 
